The invention provides compounds of formula (I) and salts thereof: R
1
-L-R
2
—B wherein R
1
, L, R
2
, and B have any of the values defined herein, as well as compositions comprising such compounds, and therapeutic methods comprising the administration of such compounds or salts. The compounds block siderophore production in bacteria and are useful as antibacterial agents.
5‘-<i>O</i>-[(<i>N</i>-Acyl)sulfamoyl]adenosines as Antitubercular Agents that Inhibit MbtA: An Adenylation Enzyme Required for Siderophore Biosynthesis of the Mycobactins
作者:Chunhua Qiao、Amol Gupte、Helena I. Boshoff、Daniel J. Wilson、Eric M. Bennett、Ravindranadh V. Somu、Clifton E. Barry、Courtney C. Aldrich
DOI:10.1021/jm070905o
日期:2007.11.1
A study of the structure-activity relationships of 5'-O-[N-(salicyl)sulfamoyl]adenosine (6), a potent inhibitor of the bifunctional enzyme salicyl-AMP ligase (MbtA, encoded by the gene Rv2384) in Mycobacterium tuberculosis, is described, targeting the salicyl moiety. A systematic series of analogues was prepared exploring the importance of substitution at the C-2 position revealing that a hydroxy group